Table 1.

Characteristics of newly diagnosed tuberculosis patients with a multiyear history of diabetes and a recent history of COVID-19

	TR-241	TR-243	TR-247
Demographicsa
Age in years, Sex	43, male	44, male	49, female
COVID-19 history
Timing prior to TB diagnosis	3 months	6 months	4 months
Anti-SARS-CoV-2 IgG at TB diagnosisb	Positive	Positive	Positive
Symptoms at the time of the COVID-19 episode:
Cough	Yes	Yes	Yes
Fever, chills	Yes	Yes	Yes
Fatigue	Yes	Yes	Yes
Loss of smell and taste	Yes	Yes	Yes
Shortness of breath	Yes	No	No
Body aches	Yes	Yes	No
Duration of TB signs and symptoms prior to reporting to the TB clinic (days)
Cough	90	180	120
Productive cough	60	90	60
Fever, chills	14	15	14
Chest pain	3	N/R	N/R
Weight loss	60	60	60
Fatigue	N/R	N/R	30
TB diagnosis
Acid-fast bacilli smear grade (bacilli/field)	> 10	> 10	> 10
M. tuberculosis culturec	Positive	Positive	Positive
TB risk factors and other medical conditions
Body mass index	13.4	23.7	29
BCG vaccine	Yes	Yes	Yes
HIV	Negative	Negative	Negative
Smoking	No	No	No
Alcohol excess and illicit drugsd	No	Yes	No
Type 2 diabetes	Yes	Yes	Yes
Years with type 2 diabetes	13 y	5 y	6 y
HbA1c	8.2%	7.5%	10.6%
Fasting blood glucose (mg/dl)	105	138	126
Diabetes medicationse	Metformin	No	Glibenclamide metformin
Other medical conditions	Peripheral neuropathy	None	High blood pressure
History of past TB or TB exposure
Self-reported past exposure to a TB patient	No	No	Yes, > 2 years ago
Prior testing for latent TB infection	No	No	No
Past history of active TB	No	No	No

N/R symptom not reported, TB tuberculosis, SARS-CoV-2 SARS coronavirus 2, COVID-19 coronavirus disease 2019, HIV Human immunodeficiency virus, HbA1c hemoglobin A1c

^aAll are Hispanic, White

^bAnti-SARS-CoV-2 IgG assay, Abbott Laboratories, Abbott Park, IL

^cM. tuberculosis spp. identified with BioLine MPT64 Rapid, Standard Diagnostics, Korea

^dTR-243: > 10 drinks and cocaine on weekends

^eTR-247: metformin 1700 mg/d; TR-249: Metformin 500 mg/d and glibenclamide 2.5 mg/day